The role of a novel self-expanding metal stent in variceal bleeding: a multicenter Australian and New Zealand experience

Autor: Saad Khan, Rajit Gilhotra, Caroline Di Jiang, David Rowbotham, Andre Chong, Avik Majumdar, Campbell White, Alex Huelsen, Jim Brooker, James O’Beirne, Cameron Schauer, Marios Efthymiou, Rhys Vaughan, Sujievvan Chandran

Publikováno v: Endoscopy International Open, Vol 10, Iss 03, Pp E238-E245 (2022)

Background and study aims Refractory variceal bleeding is associated with high mortality in patients with chronic liver disease. A fully-covered self-expanding metal stent (SEMS) has been reported to have excellent rates of technical success and init

Externí odkaz: https://doaj.org/article/17cb6b1cea59477690e557f538a316d4

Sustained clinical response to infliximab in refractory Cronkhite-Canada syndrome

Autor: Caroline Di Jiang, Helen Myint, Nigel H Stace, Andy Tie

Publikováno v: BMJ Case Rep

A 59-year-old man with refractory Cronkhite-Canada syndrome (CCS) had poor clinical response to high-dose intravenous steroids, azathioprine, total parenteral nutrition and best supportive care. He remained highly symptomatic with abdominal pain, dia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166ce10af850bdb1540a5a8022855ed4
https://pubmed.ncbi.nlm.nih.gov/33370944

effectiveness of third-class biologic treatment in crohn’s disease: a multi-center retrospective cohort study

Autor: C. M. Alves, Henit Yanai, Morine Fibelman, Claire Liefferinckx, Marina Coletta, Hadar Amir-Barak, Johan Burisch, Afroditi Mpitouli, Manuel Barreiro-de Acosta, Mohamed Attauabi, Triana Lobaton, Mariann Rutka, Joshua Taylor, Konstantinos Karmiris, Javier P. Gisbert, Carla Marinelli, Kalliopi Foteinogiannopoulou, Daniela Pugliese, Edoardo Savarino, Borja Otero-Alvarin, V Domislović, Ariella Bar-Gil Shitrit, Alessandro Armuzzi, Zeljko Krznaric, Carl Eriksson, Mohamed Korani, Waqqas Afif, Jimmy K. Limdi, Nitsan Maharshak, Davide Giuseppe Ribaldone, A Cremer, G Suris, Tamás Molnár, Stéphane Nancey, Ioannis E. Koutroubakis, Jakob Benedict Seidelin, Caroline di Jiang, Uri Kopylov, Tim Raine, Pauliina Molander, Katja Tepes, Ahmad Albshesh, David Drobne, María Chaparro, Marie Truyens, Fernando Magro

Publikováno v: Albshesh, A, Taylor, J, Savarino, E V, Truyens, M, Armuzzi, A, Ribaldone, D G, Shitrit, A B G, Fibelman, M, Molander, P, Liefferinckx, C, Nancey, S, Korani, M, Rutka, M, Acosta, M B D, Domislovic, V, Suris, G, Eriksson, C, Alves, C, Mpitouli, A, Di Jiang, C, Tepeš, K, Coletta, M, Foteinogiannopoulou, K, Gisbert, J P, Amir-Barak, H, Attauabi, M, Seidelin, J, Afif, W, Marinelli, C, Lobaton, T, Pugliese, D, Maharshak, N, Cremer, A, Limdi, J K, Molnár, T, Otero-Alvarin, B, Krznaric, Z, Magro, F, Karmiris, K, Raine, T, Drobne, D, Koutroubakis, I, Chaparro, M, Yanai, H, Burisch, J & Kopylov, U 2021, ' Effectiveness of third-class biologic treatment in crohn’s disease : A multi-center retrospective cohort study ', Journal of Clinical Medicine, vol. 10, no. 13, 2914 . https://doi.org/10.3390/jcm10132914
JOURNAL OF CLINICAL MEDICINE
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine, Vol 10, Iss 2914, p 2914 (2021)
Journal of Clinical Medicine
Volume 10
Issue 13

Background: Multiple studies have described the effectiveness of ustekinumab (UST) and vedolizumab (VDZ) in patients with Crohn’s disease (CD) failing anti- Tumor necrosis factors (TNFs)
however, the effectiveness of VDZ or UST as a third-clas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f0e8db9f808dbe7ce7e105fbfbd61d0
https://doi.org/10.3390/jcm10132914